Q1 2021 13F Holders as of 31 Mar 2021
-
Type / Class
-
Equity / Common Stock, par value $0.001 per share
-
Shares outstanding
-
28M
-
Number of holders
-
32
-
Total 13F shares, excl. options
-
1.31M
-
Shares change
-
+466K
-
Total reported value, excl. options
-
$15.5M
-
Value change
-
+$5.44M
-
Number of buys
-
24
-
Number of sells
-
-5
-
Price
-
$11.88
Significant Holders of Inmune Bio, Inc. - Common Stock, par value $0.001 per share (INMB) as of Q1 2021
35 filings reported holding INMB - Inmune Bio, Inc. - Common Stock, par value $0.001 per share as of Q1 2021.
Inmune Bio, Inc. - Common Stock, par value $0.001 per share (INMB) has 32 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 1.31M shares
of 28M outstanding shares and own 4.67% of the company stock.
Largest 10 shareholders include VANGUARD GROUP INC (313K shares), Ikarian Capital, LLC (234K shares), BlackRock Inc. (220K shares), DEUTSCHE BANK AG\ (106K shares), ROYAL BANK OF CANADA (65.5K shares), GEODE CAPITAL MANAGEMENT, LLC (60.8K shares), BANK OF MONTREAL /CAN/ (47.1K shares), MILLENNIUM MANAGEMENT LLC (42K shares), SUSQUEHANNA INTERNATIONAL GROUP, LLP (33.1K shares), and BOOTHBAY FUND MANAGEMENT, LLC (32.1K shares).
This table shows the top 32 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.